Kestra Investment Management LLC purchased a new stake in shares of MetLife, Inc. (NYSE:MET – Free Report) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor purchased 2,812 shares of the financial services provider’s stock, valued at approximately $232,000.
Other large investors have also recently added to or reduced their stakes in the company. MeadowBrook Investment Advisors LLC increased its stake in MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. grew its position in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after buying an additional 186 shares during the last quarter. Wolff Wiese Magana LLC raised its stake in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 277 shares during the period. Peterson Financial Group Inc. bought a new position in MetLife in the third quarter worth about $30,000. Finally, Fortitude Family Office LLC boosted its stake in MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 266 shares during the period. 89.81% of the stock is currently owned by institutional investors.
MetLife Price Performance
MET stock opened at $86.89 on Tuesday. MetLife, Inc. has a one year low of $63.07 and a one year high of $89.05. The firm has a 50-day moving average of $83.34 and a two-hundred day moving average of $76.61. The firm has a market capitalization of $60.16 billion, a PE ratio of 17.52, a P/E/G ratio of 0.81 and a beta of 1.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Announces Dividend
Analyst Ratings Changes
Several brokerages have weighed in on MET. Jefferies Financial Group increased their target price on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 27th. StockNews.com raised MetLife from a “hold” rating to a “buy” rating in a report on Monday, November 25th. Barclays decreased their price target on MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a research note on Thursday, October 31st. Morgan Stanley dropped their price objective on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research note on Monday, August 19th. Finally, TD Cowen raised their target price on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Fourteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $88.62.
Read Our Latest Stock Analysis on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- Short Selling: How to Short a Stock
- How to Master Trading Discipline: Overcome Emotional Challenges
- 3 Healthcare Dividend Stocks to Buy
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- Using the MarketBeat Stock Split Calculator
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.